Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
4
27%
Ph phase_4
1
7%
Ph phase_2
6
40%
Ph phase_3
1
7%
Ph phase_1
1
7%

Phase Distribution

1

Early Stage

6

Mid Stage

2

Late Stage

Phase Distribution13 total trials
Phase 1Safety & dosage
1(7.7%)
Phase 2Efficacy & side effects
6(46.2%)
Phase 3Large-scale testing
1(7.7%)
Phase 4Post-market surveillance
1(7.7%)
N/ANon-phased studies
4(30.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

8 of 10 finished

Non-Completion Rate

20.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

15

all time

Status Distribution
Active(1)
Completed(8)
Terminated(2)
Other(4)

Detailed Status

Completed8
unknown4
Withdrawn2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
15
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (7.7%)
Phase 26 (46.2%)
Phase 31 (7.7%)
Phase 41 (7.7%)
N/A4 (30.8%)

Trials by Status

not_yet_recruiting17%
completed853%
withdrawn213%
unknown427%

Recent Activity

0 active trials
Showing 5 of 15
not_yet_recruitingnot_applicable

Reducing Pain From Retinal Laser With Vibrational Stimulation

NCT06649604
withdrawnphase_2

Intravitreal Bevacizumab vs Photocoagulation for Proliferative Diabetic Retinopathy

NCT00347698
withdrawnphase_4

Avastin for Post-photocoagulation Macular Edema

NCT00801866
completedphase_2

Safety and Efficacy of Aflibercept in Proliferative Diabetic Retinopathy.

NCT02151695
completednot_applicable

The Individually-Marked Panretinal Laser phoTocoagulation for Proliferative Diabetic Retinopathy Study (TREAT)

NCT03113006
View all 15 trials

Clinical Trials (15)

Showing 15 of 15 trials
NCT06649604Not Applicable

Reducing Pain From Retinal Laser With Vibrational Stimulation

Not Yet Recruiting
NCT00347698Phase 2

Intravitreal Bevacizumab vs Photocoagulation for Proliferative Diabetic Retinopathy

Withdrawn
NCT00801866Phase 4

Avastin for Post-photocoagulation Macular Edema

Withdrawn
NCT02151695Phase 2

Safety and Efficacy of Aflibercept in Proliferative Diabetic Retinopathy.

Completed
NCT03113006Not Applicable

The Individually-Marked Panretinal Laser phoTocoagulation for Proliferative Diabetic Retinopathy Study (TREAT)

Completed
NCT02621580Not Applicable

Investigating the Structural and Functional Changes to the Retina Following PRP in Diabetic Retinopathy Patients

Completed
NCT03908723Not Applicable

Treatment of Macular Edema Caused by Leber's Miliary Aneurysms Using Intravitreal Aflibercept and Peripheral Laser Photocoagulation

Unknown
NCT03609996

Retrospective Review of Proliferative Diabetic Retinopathy Patients

Unknown
NCT03476967

Effect of Laser Treatment for Diabetic Retinopathy on the Optic Disc Topography

Completed
NCT02705274Phase 2

PRP vs Bevacizumab for PDR Treatment

Completed
NCT00841373Phase 1

Ranibizumab Supplementing Panretinal Photocoagulation as Treatment for Iris/Angle Neovascularization in Retinal Ischemic Disease

Completed
NCT01102946Phase 2

Panretinal Photocoagulation (PRP) Plus Ranibizumab for Proliferative Diabetic Retinopathy

Completed
NCT01389505Phase 2

Bevacizumab as Adjunctive Treatment to Laser Panretinal Photocoagulation for Proliferative Diabetic Retinopathy

Unknown
NCT01304225Phase 3

Panretinal Photocoagulation for Diabetic Retinopathy With PASCAL Laser

Unknown
NCT00443521Phase 2

Triamcinolone as Adjunctive Treatment to Laser Panretinal Photocoagulation for Proliferative Diabetic Retinopathy

Completed

All 15 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
15